In tumor cells, HK-II expression and binding to mitochondria are regulated by Akt/mTOR pathway.10, 20 Therefore, the specific property in tumor survival raises the possibility that pharmacological activation of Akt might protect cardiomyocyte survival by increasing mitochondrial HK-II binding. The gene discussed is AKT1; the disease is neoplasm.